Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced

Xenon Pharmaceuticals Inc. (XENE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 25,000 shares @ $38.7, valued at $967.5k
08/10/2023 4 Gover Justin D. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 28,000 options to buy @ $38.39, valued at $1.1M
08/10/2023 3 Gover Justin D. (Director) has filed a Form 3 on Xenon Pharmaceuticals Inc.
08/10/2023 4 Cannon Gillian (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 28,000 options to buy @ $38.39, valued at $1.1M
08/10/2023 3 Cannon Gillian (Director) has filed a Form 3 on Xenon Pharmaceuticals Inc.
06/02/2023 4 AZAB MOHAMMAD (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/02/2023 4 PATOU GARY (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/02/2023 4 GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/02/2023 4 Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/02/2023 4 GAROFALO ELIZABETH A. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/02/2023 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/02/2023 4 Machado Patrick (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/01/2023 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 18,006 shares @ $38.63, valued at $695.6k
Sold 19,000 shares @ $39.9, valued at $758.1k
Sold 12,000 shares @ $38.53, valued at $462.4k
Exercised 29,835 shares @ $9.85, valued at $293.9k
Paid exercise price by delivering 6,165 shares @ $38.37, valued at $236.6k
Sold 23,670 shares @ $38.81, valued at $918.6k
Paid exercise price by delivering 23,144 shares @ $38.37, valued at $888k
Sold 26,856 shares @ $38.69, valued at $1M
Paid exercise price by delivering 1,860 shares @ $38.53, valued at $71.7k
Sold 7,458 shares @ $38.97, valued at $290.6k
Paid exercise price by delivering 20,745 shares @ $38.53, valued at $799.3k
05/26/2023 4 MORTIMER IAN (PRESIDENT & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 42,592 shares @ $9.44, valued at $402.1k
Paid exercise price by delivering 7,310 shares @ $41.84, valued at $305.9k
Sold 17,069 shares @ $41.44, valued at $707.3k
Exercised 20,576 shares @ $9.85, valued at $202.7k
Paid exercise price by delivering 3,902 shares @ $41.84, valued at $163.3k
Sold 13,179 shares @ $41.37, valued at $545.2k
Exercised 6,172 shares @ $9.85, valued at $60.8k
Paid exercise price by delivering 1,171 shares @ $41.84, valued at $49k
Sold 1,407 shares @ $41.49, valued at $58.4k
Exercised 42,592 options to buy @ $0
Exercised 20,576 options to buy @ $0
03/24/2023 4 KENNEY CHRISTOPHER JOHN (Chief Medical Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 700 shares @ $35.01, valued at $24.5k
03/14/2023 4 Von Seggern Christopher (Chief Commercial Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 90,000 options to buy @ $34.18, valued at $3.1M
03/14/2023 4 ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 75,000 options to buy @ $34.18, valued at $2.6M
03/14/2023 4 DiFabio Andrea (Chief Legal Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 45,000 options to buy @ $34.18, valued at $1.5M
03/14/2023 4 MORTIMER IAN (PRESIDENT & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 380,000 options to buy @ $34.18, valued at $13M
03/14/2023 4 KENNEY CHRISTOPHER JOHN (Chief Medical Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 120,000 options to buy @ $34.18, valued at $4.1M
03/14/2023 4 EMPFIELD JAMES R. (EVP, Drug Discovery) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 75,000 options to buy @ $34.18, valued at $2.6M
03/14/2023 4 AULIN SHERRY (CFO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 120,000 options to buy @ $34.18, valued at $4.1M
03/09/2023 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 41,152 shares @ $2.68, valued at $110.3k
Paid exercise price by delivering 2,160 shares @ $37.13, valued at $80.2k
Sold 10,990 shares @ $37.01, valued at $406.7k
Exercised 30,864 shares @ $2.59, valued at $79.9k
Paid exercise price by delivering 1,618 shares @ $37.13, valued at $60.1k
Sold 8,242 shares @ $36.94, valued at $304.5k
Exercised 41,152 options to buy @ $0
Exercised 30,864 options to buy @ $0
12/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/07/2022 4 AULIN SHERRY (CFO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Paid exercise price by delivering 3,293 shares @ $39.53, valued at $130.2k
Sold 15,355 shares @ $39.57, valued at $607.6k
Exercised 9,000 options to buy @ $9.44, valued at $85k
Exercised 32 options to buy @ $7.49, valued at $239.7
Exercised 813 options to buy @ $8.4, valued at $6.8k
Exercised 2,292 options to buy @ $3.1, valued at $7.1k
Exercised 6,511 options to buy @ $4.75, valued at $30.9k
09/02/2022 4 ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Paid exercise price by delivering 1,572 shares @ $37.86, valued at $59.5k
Sold 21,352 shares @ $38.57, valued at $823.5k
Paid exercise price by delivering 6,121 shares @ $38.81, valued at $237.6k
Sold 35,103 shares @ $38.03, valued at $1.3M
Sold 8,776 shares @ $38.8, valued at $340.5k
Exercised 17,488 options to buy @ $2.67, valued at $46.7k
Exercised 5,000 options to buy @ $4.75, valued at $23.8k
Exercised 50,000 options to buy @ $4.75, valued at $237.5k
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2022 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 43,135 shares @ $37.91, valued at $1.6M
Sold 47,000 shares @ $38.6, valued at $1.8M
Sold 1,000 shares @ $39.15, valued at $39.2k
Sold 33,942 shares @ $37.76, valued at $1.3M
Sold 32,058 shares @ $38.29, valued at $1.2M
Sold 20,000 shares @ $38.87, valued at $777.4k
06/29/2022 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,000 options to buy @ $30.11, valued at $542k
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy